Showing results (51-60 of 183) with videos related to
Sort By:
Pageof 19
Heliyon|September 12, 2019
Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor modelIrfana Muqbil, Mahmoud Chaker, Amro Aboukameel, et al.American Journal of Physiology. Cell Physiology|October 24, 2022
Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexiaMd Hafiz Uddin, Ramzi M Mohammad, Philip A Philip, et al.Anticancer Research|April 22, 2011
Targeting notch to eradicate pancreatic cancer stem cells for cancer therapyZhiwei Wang, Aamir Ahmad, Yiwei Li, et al.Molecular Cancer Therapeutics|November 3, 2010
Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinationsAsfar S Azmi, Zhiwei Wang, Philip A Philip, et al.Expert Opinion on Emerging Drugs|September 4, 2010
Emerging Bcl-2 inhibitors for the treatment of cancerAsfar S Azmi, Zhiwei Wang, Philip A Philip, et al.Journal of Nanoscience and Nanotechnology|February 15, 2018
Carbonyl Functionalized Single-Walled Carbon Nanotube-Hb Crosslinked Network: A Novel Platform for Studying Bio-Electrochemistry and Electrocatalysis of HemoglobinA K M Kafi, C C L Yam, N S Azmi, et al.Molecular Cancer|November 19, 2021
Circular RNAs in acute myeloid leukemiaVijendra Singh, Mohammed Hafiz Uddin, Jeffrey A Zonder, et al.Chemotherapy|August 18, 2010
Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen speciesS M Hadi, M F Ullah, U Shamim, et al.Current Drug Targets|July 10, 2013
Nuclear export mediated regulation of microRNAs: potential target for drug interventionIrfana Muqbil, Bin Bao, Abdul Badi Abou-Samra, et al.Current Pharmaceutical Design|February 1, 2014
Regulation of KRAS-PAK4 axis by microRNAs in cancerZeshan S Choudhry, Vraj Tripathi, Mike Sutton, et al.Pageof 19